Because tumor-infiltrating Treg cells suppress the activation of tumor antigen-specific CD8+ T cells, a greater proportion of Treg cells to CD8+ T cells among tumor-infiltrating lymphocytes is associated with poor prognosis in several cancers (Nishikawa and Sakaguchi, 2010). The gene discussed is CD8A; the disease is cancer.